US Patent 7223399 Methods for treating restenosis with a

Patent 7223399 was granted and assigned to Allergan, Inc. on May, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Allergan, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7223399

Date of Patent

May 29, 2007

Patent Application Number

11345736

Date Filed

February 1, 2006

Patent Primary Examiner

‌

Robert A Zeman

Patent abstract

The present invention provides for methods of treating cardiovascular diseases in a mammal. The methods include a step of administering an effective amount of a botulinum toxin directly to a blood vessel of a mammal thereby treating a cardiovascular disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7223399 Methods for treating restenosis with a

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API